A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Arsenic, Blood (NY)
Test Code13659
CPT Codes
82175<br><strong>This is for New York patient testing. For non-New York patient testing, use test code 269.</strong>
Preferred Specimen
4 mL whole blood collected in an EDTA (royal blue-top) tube
Patient Preparation
Avoid seafood consumption for 48 hours prior to sample collection
Minimum Volume
2 mL
Other Acceptable Specimens
Sodium heparin (royal blue-top) tube
Instructions
Carefully clean skin prior to venipuncture. Avoid worksite collection.
Note: Tests performed on a specimen submitted in a non-trace element tube/container (non-acid washed) may not accurately reflect the patient's level. If a non-trace element tube/ container is received, it will be accepted for testing. However, elevated results shall be reported with a message that re-submission with a trace element tube/container is recommended.
Note: Tests performed on a specimen submitted in a non-trace element tube/container (non-acid washed) may not accurately reflect the patient's level. If a non-trace element tube/ container is received, it will be accepted for testing. However, elevated results shall be reported with a message that re-submission with a trace element tube/container is recommended.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable
Refrigerated: 10 days
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Clotted specimen
Methodology
Inductively Coupled Plasma/Mass Spectrometry (ICP/MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues, Thurs, Sat; Report available: 1-4 days
Limitations
Arsenic may only be present in blood for 4-6 hours. This test is most accurate in acute poisoning.
Clinical Significance
This assay is used to monitor exposure to arsenic, wellness, and therapy during treatment of chronic myelocytic leukemia.